Robert Eugene Watson

CIK: 0001511858

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CVM

CEL SCI CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CVM
CEL SCI CORP
Aug 14, 2026
Award(A)
Options
Direct
110K shares at avg. $0.01-
CVM
CEL SCI CORP
Jul 28, 2025
Award(A)
Options
Direct
4K shares at avg. $0.01-
CVM
CEL SCI CORP
Jul 25, 2025
Purchase(P)
Direct
2.9K shares at avg. $6.85$20K

		Type	Shares	Price		Ownership
Aug 14, 2026	CVM CEL SCI CORP	Award(A) Options	110,000	$0.01	-	Direct
Jul 28, 2025	CVM CEL SCI CORP	Award(A) Options	4,000	$0.01	-	Direct
Jul 25, 2025	CVM CEL SCI CORP	Purchase(P)	2,919	$6.85	$19,995	Direct

1-3 of 3 transactions

About Watson Robert Eugene

Watson Robert Eugene (SEC CIK 0001511858) files insider reports with the SEC as Director of CEL SCI CORP (CVM).

Signal8 holds 3 ownership filings by Watson Robert Eugene, all Form 4s, filed between Jul 29, 2025 and Aug 17, 2026. Those filings report 3 transactions, from Jul 25, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Watson Robert Eugene's filings is in WEAVERVILLE, NC.

Recent filings by Watson Robert Eugene

Aug 14, 2026: Grant or award of CVM derivative securities (Form 4, code A).
Jul 28, 2025: Grant or award of CVM derivative securities (Form 4, code A).
Jul 25, 2025: Open-market purchase of CVM shares (Form 4, code P).

Other insiders filing for CEL SCI CORP (CVM)

TALOR EYAL, Chief Scientific Officer
PRICHEP PATRICIA B, Chief Financial Officer
KERSTEN GEERT R, Chief Executive Officer
BAILLAVOINE BRUNO JEAN-MARIE, Director
CIPRIANO JOHN, Senior Vice President

How to read Form 4 transaction codes